183 related articles for article (PubMed ID: 35769548)
1. Scintigraphic Imaging of Neovascularization With
Jin X; Dong C; Zheng K; Shi X; Liu Y; Huo L; Wang F; Li F
Front Oncol; 2021; 11():792431. PubMed ID: 35769548
[TBL] [Abstract][Full Text] [Related]
2.
Sun W; He G; Zhang M; Zhao Y; Yu H; Li Y; Wu W; Ji T
Dose Response; 2019; 17(4):1559325819882544. PubMed ID: 31673250
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of neovascularization with (68)Ga-3PRGD2 for assessing tumor early response to Endostar antiangiogenic therapy.
Shi J; Jin Z; Liu X; Fan D; Sun Y; Zhao H; Zhu Z; Liu Z; Jia B; Wang F
Mol Pharm; 2014 Nov; 11(11):3915-22. PubMed ID: 25158145
[TBL] [Abstract][Full Text] [Related]
4. Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with Endostar.
Shi J; Fan D; Dong C; Liu H; Jia B; Zhao H; Jin X; Liu Z; Li F; Wang F
Theranostics; 2014; 4(3):256-66. PubMed ID: 24505234
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of
Zheng J; Miao W; Huang C; Lin H
Ann Nucl Med; 2017 Jul; 31(6):486-494. PubMed ID: 28474165
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of integrin α
Liang Y; Jia X; Wang Y; Liu Y; Yao X; Bai Y; Han P; Chen S; Yang A; Gao R
Cancer Imaging; 2022 Dec; 22(1):72. PubMed ID: 36536432
[TBL] [Abstract][Full Text] [Related]
7. Small-Animal SPECT/CT of the Progression and Recovery of Rat Liver Fibrosis by Using an Integrin αvβ3-targeting Radiotracer.
Yu X; Wu Y; Liu H; Gao L; Sun X; Zhang C; Shi J; Zhao H; Jia B; Liu Z; Wang F
Radiology; 2016 May; 279(2):502-12. PubMed ID: 26669696
[TBL] [Abstract][Full Text] [Related]
8. Comparison of [
Chen Z; Fu F; Li F; Zhu Z; Yang Y; Chen X; Jia B; Zheng S; Huang C; Miao W
Mol Imaging Biol; 2018 Oct; 20(5):846-856. PubMed ID: 29497956
[TBL] [Abstract][Full Text] [Related]
9. Assessing activation of hepatic stellate cells by (99m)Tc-3PRGD2 scintigraphy targeting integrin αvβ3: a feasibility study.
Zhang X; Xin J; Shi Y; Xu W; Yu S; Yang Z; Liu C; Cao L; Guo Q
Nucl Med Biol; 2015 Mar; 42(3):250-5. PubMed ID: 25530210
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive detection of human-induced pluripotent stem cell (hiPSC)-derived teratoma with an integrin-targeting agent (99m)Tc-3PRGD2.
Li Y; Liu Z; Dong C; He P; Liu X; Zhu Z; Jia B; Li F; Wang F
Mol Imaging Biol; 2013 Feb; 15(1):58-67. PubMed ID: 22707047
[TBL] [Abstract][Full Text] [Related]
11. ⁹⁹mTc-3PRGD₂ SPECT to monitor early response to neoadjuvant chemotherapy in stage II and III breast cancer.
Ji B; Chen B; Wang T; Song Y; Chen M; Ji T; Wang X; Gao S; Ma Q
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1362-70. PubMed ID: 25947573
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Hepatocellular Carcinoma by Intratumoral Injection of
Zhou J; Hu P; Si Z; Tan H; Qiu L; Zhang H; Fu Z; Mao W; Cheng D; Shi H
Front Bioeng Biotechnol; 2019; 7():319. PubMed ID: 31799244
[No Abstract] [Full Text] [Related]
13. Evaluation of
Wu Y; Wang Y; Yang Z; Teng C; Guo Z
Thorac Cancer; 2022 Nov; 13(21):3025-3031. PubMed ID: 36104010
[TBL] [Abstract][Full Text] [Related]
14. Integrin αvβ3 imaging of radioactive iodine-refractory thyroid cancer using 99mTc-3PRGD2.
Zhao D; Jin X; Li F; Liang J; Lin Y
J Nucl Med; 2012 Dec; 53(12):1872-7. PubMed ID: 23071350
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-3PRGD2 for integrin receptor imaging of lung cancer: a multicenter study.
Zhu Z; Miao W; Li Q; Dai H; Ma Q; Wang F; Yang A; Jia B; Jing X; Liu S; Shi J; Liu Z; Zhao Z; Wang F; Li F
J Nucl Med; 2012 May; 53(5):716-22. PubMed ID: 22499615
[TBL] [Abstract][Full Text] [Related]
16. Assessing Doxorubicin-Induced Cardiomyopathy by 99mTc-3PRGD2 Scintigraphy Targeting Integrin αvβ3 in a Rat Model.
Sui S; Hou Y
Nuklearmedizin; 2021 Aug; 60(4):289-298. PubMed ID: 33638136
[TBL] [Abstract][Full Text] [Related]
17. Utility of Tc-PEG4-E[PEG4-c(RGDfK)]2 in Posttherapy Surveillance of Patients with Reelevated Carcinoembryonic Antigen Levels.
Gao R; Zhang G; Chen L; Zhu Z; Wang F; Yang A
Med Princ Pract; 2015; 24(3):244-9. PubMed ID: 25871432
[TBL] [Abstract][Full Text] [Related]
18. Integrin Imaging with
Jin X; Liang N; Wang M; Meng Y; Jia B; Shi X; Li S; Luo J; Luo Y; Cui Q; Zheng K; Liu Z; Shi J; Li F; Wang F; Zhu Z
Radiology; 2016 Dec; 281(3):958-966. PubMed ID: 27479638
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal monitoring of tumor antiangiogenic therapy with near-infrared fluorophore-labeled agents targeted to integrin αvβ3 and vascular endothelial growth factor.
Sun X; Ma T; Liu H; Yu X; Wu Y; Shi J; Jia B; Zhao H; Wang F; Liu Z
Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1428-39. PubMed ID: 24562646
[TBL] [Abstract][Full Text] [Related]
20. (99m)Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma.
Zhang Z; Zhao X; Ding C; Wang J; Zhang J; Wang F
Cancer Biother Radiopharm; 2016 Sep; 31(7):238-45. PubMed ID: 27563805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
